rhizobitoxine: toxic substance found in extracts of R. japonicum; believed to be helpful in protecting soybean roots from M. phaseolina infection
ID Source | ID |
---|---|
PubMed CID | 6436603 |
SCHEMBL ID | 14753555 |
MeSH ID | M0123349 |
Synonym |
---|
rhizobitoxine |
(e,2s)-2-amino-4-[(2r)-2-amino-3-hydroxypropoxy]but-3-enoic acid |
unii-h4jex49o4k |
37658-95-0 |
3-butenoic acid, 2-amino-4-(2-amino-3-hydroxypropoxy)-, (s-(r*,s*-(e)))- |
h4jex49o4k , |
SCHEMBL14753555 |
(2s,3e)-2-amino-4-[(2r)-2-amino-3-hydroxypropoxy]but-3-enoate |
rhizobitoxin |
rhizobutoxine |
(2s,3e)-2-amino-4-((2r)-2-amino-3-hydroxypropoxy)-3-butenoic acid |
3-butenoic acid, 2-amino-4-((2r)-2-amino-3-hydroxypropoxy)-, (2s,3e) |
C21887 |
Rhizobitoxine is a phytotoxin synthesized by some strains of the legume symbiont genus Bradyrhizobium and the plant pathogen Pseudomonas andropogonis.
Excerpt | Reference | Relevance |
---|---|---|
"Rhizobitoxine is a phytotoxin synthesized by some strains of the legume symbiont genus Bradyrhizobium and the plant pathogen Pseudomonas andropogonis. " | ( Rapid and sensitive assay for the phytotoxin rhizobitoxine. Peters, NK; Ruan, X, 1991) | 1.98 |
Excerpt | Reference | Relevance |
---|---|---|
"Rhizobitoxine did not cause cell death at a concentration sufficient to eliminate hydrogenase expression." | ( Rhizobitoxine inhibition of hydrogenase synthesis in free-living Bradyrhizobium japonicum. Asami, T; Fukai, K; Minamisawa, K, 1990) | 2.44 |
Excerpt | Relevance | Reference |
---|---|---|
" Dosage response curves with rhizobitoxine showed it to be antifungal." | ( Role of rhizobitoxine in protecting soybean roots from Macrophomina phaseolina infection. Chakraborty, U; Purkayastha, RP, 1984) | 0.99 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 1 (5.88) | 18.7374 |
1990's | 4 (23.53) | 18.2507 |
2000's | 10 (58.82) | 29.6817 |
2010's | 2 (11.76) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (22.63) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 2 (11.11%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 16 (88.89%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |